TriLink BioTechnologies

Chemically Modified Primers for Improved Multiplexed PCR

Elena Hidalgo Ashrafi, Tony Le, Alexandre Lebedev, Richard Hogrefe, Victor Timoshchuk, Sabrina Shore, Inna Koukhareva and Natasha Paul, TriLink BioTechnologies

Date Posted: Friday, January 08, 2010

Print Email to a friend

Multiplex PCR is an advantageous technique used in PCR applications to amplify multiple targets in a single reaction. As useful as it is, this technique presents a new set of challenges that further complicates PCR setup. For example, reactions are more prone to off-target amplifications such as mis-priming and primer dimer due to the increased number of primer pairs. Furthermore, preferential amplification of certain targets leads to an unequal distribution of amplicon products, making quantification and detection of problematic targets extremely difficult. To improve upon the problems specific to multiplex PCR, we evaluated Hot Start modified primers which contain either one or two thermolabile 4-oxo-tetradecyl (OXT) modifications to prevent DNA polymerase extension at low-stringent temperatures, and that are released after a Hot Start activation step. Herein, we find that the singly-modified primers provide greater amplification efficiency, specificity, and yield in the multiplex amplification of DNA targets. In reverse transcriptase PCR (RT-PCR), the doubly-modified primers have been proven to be the optimal choice. The presence of two thermolabile protecting groups allows for an efficient one-step RT-PCR reaction that provides high specificity for multiple targets. TriLink’s innovative technology represents a convenient tool for multiplex PCR amplification of DNA and RNA samples.

Click here to open poster PDF


Comments about this Poster

Click Here to Leave a Comment about this Poster



Related news from our archive

TriLink Announces Sales and License Agreement with Glen Research for CleanAmp™ Amidites
Glen Research can now sell the patented CleanAmp™ Amidites to third parties for use in production of CleanAmp™ Primers.

TriLink BioTechnologies Announces Supply Agreement with Osmetech Molecular Diagnostics
TriLink to supply reagents for Osmetech's eSensor® cystic fibrosis carrier detection system and the eSensor® XT-8 System for Warfarin sensitivity.

TriLink Biotechnologies Announces Supplier Agreement with Applied Biosystems
TriLink to provide Applied Biosystems with custom dye-labeled oligonucleotides which are used as part of the DNA sequencing process.

TriLink Awarded Phase I Grant for a Second Hot Start PCR Project
TriLink Biotechnologies has received a $100,000 Phase I SBIR grant from the National Institutes of Health, to study an approach to PCR activation.